Pricing Log in Create free account

Atea Pharmaceuticals, Inc. (AVIR) vs Contineum Therapeutics, Inc. (CTNM)

Atea Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. are of similar size ($345.9M and $338.5M). Across the 9 metrics below, Contineum Therapeutics, Inc. leads on 6 and Atea Pharmaceuticals, Inc. on 3.

Valuation

Metric AVIR CTNM Biotechnology median
P/E n/m n/m 10.60
P/S 0.98 n/m 9.40
P/B 1.68 1.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.35 n/m 9.02
Earnings yield (48.48%) (18.76%) (32.88%)
Free cash flow yield (160.13%) (14.44%) (23.13%)

Profitability

Metric AVIR CTNM Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.14%) (29.80%) (51.96%)
Return on assets (52.99%) (28.34%) (46.06%)
Return on invested capital 0.00% (4,845.62%) 0.00%

Growth

Metric AVIR CTNM Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 3.00% 0.46% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AVIR CTNM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.13 31.11 4.97
Net debt to EBITDA 1.63 3.88 1.01

Dividend

Metric AVIR CTNM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AVIR CTNM Biotechnology median
Market cap 338.46m 345.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack